Pediatric arrhythmias: Which are the news?

Journal of Cardiovascular Medicine

Volumn 8, Issue 1, 2007, Pages 62-66

  Vignati, Gabriele ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Arrhythmias; Congenital heart defects; Pediatric cardiology

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CATHETER ABLATION; DEFIBRILLATOR; DISEASE SEVERITY; ELECTROCARDIOGRAM; EXERCISE TEST; FETUS HEART RATE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HOLTER MONITORING; HUMAN; LONG QT SYNDROME; MEDICAL DECISION MAKING; PACEMAKER; POLYMORPHIC VENTRICULAR TACHYCARDIA; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; WOLFF PARKINSON WHITE SYNDROME; X RAY;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CATHETER ABLATION; CHILD; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FETAL DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; ULTRASONOGRAPHY, PRENATAL;

EID: 33846623778     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000247438.12817.9e     Document Type: Review

References (40)

1. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79:576-581.
2. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus - a report of 60 cases. Ultrasound Obstet Gynecol 1991; 1:162-168.
3. D'Souza D, MacKenzie WE, Martin WL. Transplacental flecainide therapy in the treatment of fetal supraventricular tachycardia. J Obstet Gynaecol 2002; 22:320-322.
4. Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003; 42:765-770.
5. Khositseth A, Ramin KD, O'Leary PW, Porter CJ. Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis. Pediatr Cardiol 2003; 24:454-456.
6. Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M, et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 2005; 26:4-15.
7. Vignati G, Brucatao A, Pisoni MP, Pome G, La Placa S, Mauri L, Lunati M. Evoluzione pre e postatale del blocco atrioventricolare congenito isolato diagnosticato in utero. G Ital Cardiol 1999; 29:1478-1487.
8. Buyon JP, Clancy RM. Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 2005; 31:299-313.
9. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003; 62:1010-1012.
10. Raboisson MJ, Fouron JC, Sonesson SE, Nyman M, Proulx F, Gamache S. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr 2005; 18:375-380.
11. Hickstein H, Kulz T, Claus R, Stange J, Schmidt R. Autoimmune-associated congenital heart block: treatment of the mother with immunoadsorption. Ther Apher Dial 2005; 9:148-153.
12. Collen EC, Yoram R. Na channel mutation that causes both Brugada and long-QT syndrome phenotypes. Circulation 2002; 105:1208-1213.
13. Priori S, Napolitano C, Tiso T, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac Ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103:196-200.
14. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis and treatment. Heart 2000; 83:588-595.
15. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome. Gene specific triggers for life threatening arrhythmias. Circulation 2001; 103:89-95.
16. Priori SG, Barhanin J, Hauer RNW, Haverkamp W, Jongsma HJ, Kleber AG, et al. Genetic and molecular basis of cardiac arrhythmias impact on clinical management. Circulation 1999; 99:674-681.
17. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy; task force of the working group myocardial pericardial disease of the European Society of Cardiology and Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71:215-218.
18. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995; 91:1512-1519.
19. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2002; 22:1374-1450.
20. Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2001; 38:1773-1781.
21. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10:189-194.
22. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002; 40: 446-452.
23. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation 2004; 110:1879-1884.
24. Perry JC, Garson A Jr. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990; 16:1215-1220.
25. Kugler JD, Danford DA. Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996; 129:324-338.
26. Kugler JD, Danford DA, Houston K, Felix G. Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol 2002; 13:336-341.
27. Campbell RM, Strieper MJ, Frais PA, Danford DA, Kugler JD. Current status of radiofrequency ablation for common pediatric supraventricular tachycardia. J Pediatr 2002; 140:150-155.
28. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301:1080-1085.
29. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County Minnesota 1953-1989. Circulation 1993; 87:866-873.
30. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 1995; 76:492-494.
31. Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G, et al. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med 2004; 351:1197-1205.
32. Sharma AD, Yee R, Guiraudon G, Klein GJ. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987; 10:373-381.
33. Vignati G, Balla E, Mauri L, Lunati M, Figini A. Clinical and electrophysiologic evolution of the Wolff-Parkinson-White syndrome in children: impact on approaches to management. Cardiol Young 2000; 10:367-375.
34. Zipes DP, Dimarco JP, Gillette PC, Jackman WM, Myerburg RJ, Rahimtoola SH, et al. ACC/AHA Task Force report: guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. J Am Coll Cardiol 1995; 26:555-573.
35. Campbell RM, Strieper MJ, Frias PA, Collins KK, Van Hare GF, Dubin AM. Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome. Pediatrics 2003; 111:245-247.
36. Van Hare GF, Dubin AM, Collins KK. Invasive electrophysiology in children: state of the art. J Electrocardiol 2002; 35 (suppl):165-174.
37. Sporton SC, Earley MJ, Nathan AW, Schilling RJ. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol 2004; 15:310-315.
38. Kirsh JA, Gross GJ, O'Connor S, Hamilton RM. Cryocath International Patient Registry. Transcatheter cryoablation of tachyarrhythmias in children: initial experience from an international registry. J Am Coll Cardiol 2005; 45:133-136.
39. Kammeraad JA, Rosenthal E, Bostock J, Rogers J, Sreeram N. Endocardial pacemaker implantation in infants weighing < or = 10 kilograms. Pacing Clin Electrophysiol 2004; 27:1466-1474.
40. Ten Harkel AD, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MT. Implantable cardioverter defibrillator implantation in children in The Netherlands. Eur J Pediatr 2005; 164:436-441.